COMP <GO>
ULS vs LLY // PIOTROSKI F-SCORE QUALITY
UL Solutions Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: ULS 4
— LLY 11
▲ PIOTROSKI F-SCORE QUALITY LEADER: LLY
LAST: $74.76 (-0.93%) • MKT CAP: $15.24B
piotroski-score
8/9
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
piotroski-score
9/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULS VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULS | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.50% | 83.64% | -34.14 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.30% | 32.36% | -4.06 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.4x | 36.4x | -14.02 | ULS | /valuation <GO> |
| Free Cash Flow Yield | 2.65% | 2.30% | +0.35 | ULS | /fcf-yield <GO> |
| Operating Margin | 17.10% | 40.21% | -23.11 | LLY | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 31.90% | -21.30 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 45.51% | -39.11 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.68% | 0.49% | +0.19 | ULS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.58 | 9.29 | -1.71 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.77% | +0.43 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.1 | 77.9 | -16.80 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.51 | +0.57 | ULS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.6x | 26.3x | +17.35 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.24B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULS REV | LLY REV | ULS GROSS % | LLY GROSS % | ULS FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.05B | $65.18B | 49.5% | 83.0% | $403.0M | $16.81B |
| FY 2024 | $2.87B | $45.04B | 48.5% | 81.3% | $287.0M | $8.82B |
| FY 2023 | $2.68B | $34.12B | 44.0% | 79.3% | $346.5M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULS // BETA 1.08
LLY // BETA 0.51